The New Age of -omics in Urothelial Cancer – Re-wording Its Diagnosis and Treatment

Por Theodora Katsila, Michalis Liontos, George P. Patrinos, Aristotelis Bamias, Dimitrios Kardamakis
Publicado em 2018-02-01

Retrospective analysis of bevacizumab-induced arthralgia and clinical outcomes in ovarian cancer patients. Single center experience

Por Maria Kaparelou, Michalis Liontos, Pelagia Katsimbri, Aggeliki Andrikopoulou, Alikistis Papatheodoridi, Anastasios Kyriazoglou, Aristotelis Bamias, Flora Zagouri, Meletios Athanasios Dimopoulos
Publicado em 2022-04-01

Aberrant DNA damage response pathways may predict the outcome of platinum chemotherapy in ovarian cancer.

Por Dimitra T Stefanou, Aristotelis Bamias, Hara Episkopou, Soterios A Kyrtopoulos, Maria Likka, Theodore Kalampokas, Stylianos Photiou, Nikos Gavalas, Petros P Sfikakis, Meletios A Dimopoulos, Vassilis L Souliotis
Publicado em 2015-01-01

Antitumor Reactive T-Cell Responses Are Enhanced In Vivo by DAMP Prothymosin Alpha and Its C-Terminal Decapeptide

Por Anastasios I. Birmpilis, Chrysoula-Evangelia Karachaliou, Pinelopi Samara, Kyriaki Ioannou, Platon Selemenakis, Ioannis V. Kostopoulos, Nadia Kavrochorianou, Hubert Kalbacher, Evangelia Livaniou, Sylva Haralambous, Athanasios Kotsinas, Farzin Farzaneh, Ioannis P. Trougakos, Wolfgang Voelter, Meletios-Athanasios Dimopoulos, Aristotelis Bamias, Ourania Tsitsilonis
Publicado em 2019-11-01